Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (8) , e678-e679
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experienceBone Marrow Transplantation, 2016
- The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B‐cell lymphomaBritish Journal of Haematology, 2008
- Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in JapanJournal of Clinical Oncology, 2008
- Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus MeetingJournal of Clinical Oncology, 2007
- Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomaBone Marrow Transplantation, 2005
- Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1British Journal of Haematology, 2004
- Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaAnnals of Oncology, 2004
- Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosisBone Marrow Transplantation, 2001